Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cenovus Energy Inc (CVE) vs Twist Bioscience Corp (TWST) Price & Performance

Cenovus Energy IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Cenovus Energy Inc vs Twist Bioscience Corp — how do they compare? Cenovus Energy Inc trades at $31.73 (market cap $57.90B), while Twist Bioscience Corp trades at $158.89 (market cap $10.08B). The key difference: Cenovus Energy Inc is far larger — about 5.7× Twist Bioscience Corp's market cap, and Cenovus Energy Inc pays a 1.97% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Twist Bioscience Corp for 27 Days on average.

CVETWST
Market Cap
$57.90B$10.08B
Volume
7,863,5884,229,037
Sector
EnergyHealth
52-Week High
$33.92$205.00
52-Week Low
$15.85$25.45
Typical Hold Time
46 Days27 Days
Enterprise Value
$63.84B$10.01B
Dividend Yield
1.97%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cenovus Energy Inc

Cenovus Energy (CVE) trades at $30.63, down 1.95% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong profitability with a 20.96% ROE and 11.48% net margin, supported by recent earnings beats. Cash flow trends indicate operational strength, though net cash flow was negative $353 million in 2025. Analyst sentiment is mixed with 40.74% buy ratings, while recent news highlights growth potential and value attributes.

Outlook: CVE offers value with a low P/E of 12.43 and solid earnings growth projections, but faces headwinds from volatile oil prices and mixed technical indicators. Risks include energy market fluctuations and debt levels, though institutional interest remains steady. The stock presents a balanced opportunity for value investors seeking energy exposure.

Twist Bioscience Corp

TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.

The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVE
18% Buy82% Sell
Avg holding period · 46 Days
TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Cenovus Energy Inc

Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.

Read more on CVE →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →